Market Definition 

A cystoscope is a thin tube with a camera and light on the end. In the cystoscopy procedure cystoscope is inserted through the urethra and into the bladder which helps to visualize the inside of the bladder. The cystoscope has lenses like a telescope or microscope. 

Global cystoscope market is estimated to reach $XX million by 2027, growing at a CAGR of 6.2% till 2027. 

Market Dynamics 

Rising prevalence and incidence of urinary tract diseases and urinary incontinence is boosting the market growth. For instance, according to National Kidney Foundation, urinary tract infection (UTI) is responsible for nearly 10 million doctor visits each year. Around 60% of women and 12% of men have at least one urinary tract infection during their lifetime. Urinary tract infection in women is very common, approximately 25 to 40% of women in the United States aged 20-40 years had urinary tract infection. urinary tract infection account for around 6 million patient visits to physicians each year in the United States. Urinary incontinence affects over 423 million people by 2018. Around 25 million American adults suffering from some form of urinary incontinence. According to Continence Foundation of Australia, around 5 million Australians experienced bladder or bowel control problems in 2018. Urinary incontinence affects 13% of Australian men and about 37% of Australian women in 2018. Further, increasing regulatory approval of cystoscope are key driving factors of the market. However, risk associated with cystoscopy procedure might hamper the market growth. Moreover, increasing technological advancement for the growth of imaging technology such as narrow band imaging for targeting bladder tumor biopsies would provide lucrative opportunities for the market in coming years. 

Market Segmentation 

The global cystoscope market is mainly classified based on type, application, and end use. Type is further segmented into Flexible Cystoscope and Rigid Cystoscope. By application the market is divided into Urology, Gynaecology, and Others. By end user the market is further divided into Hospitals, Ambulatory Surgical Centers, and Others. 

Flexible Cystoscope has shown significant growth in 2020 owing to the collaboration between companies to develop and market flexible cystoscope, increasing regulatory approval for flexible cystoscope and commercialization of new technologically advanced flexible cystoscope. For instance, Ambu, has introduced a single-use flexible cystoscope. Scope 4 cysto disposable cystoscope Used for visualization within the bladder during diagnostic and interventional procedures.  

Regional Analysis 

Based on geography, the global cystoscope market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

North America was dominating the cystoscope market in 2020, due to the rising incidence of urinary tract diseases and urinary incontinence, partnership between companies to develop and supply cystoscope, and increasing commercialization of regulatory approved cystoscope. For instance, UroViu Corporation has received 510(k) clearance from the US Food and Drug Administration for Uro-V single-use diagnostic cystoscopic system. The Uro-V single-use disposable, semi-flexible, easy-to-use, and patient-friendly Uro-V System represents a major advance in diagnostic cystoscopy. Additionally, the United States Patent and Trademark Office has issued a patent for Uro-V System to UroViu. 

Competitive landscape 

Key players operating in the cystoscope industry include Olympus Corporation, Stryker Corporation, Karl Storz SE & Co. KG, Advanced Endoscopy Devices, Inc., Richard Wolf GmbH, Maxer Medizintechnik GmbH, NeoScope Inc., PENTAX Medical, Coloplast Group, and Laborie, Inc. 

Strategic acquisition between companies to generate revenue and expand its market presence for cystoscope, Commercialization of regulatory approved cystoscope, and strategic agreement between companies to deliver cystoscope are some of the strategies adopted by the major companies. For instance, on September 8, 2020, Ambu Inc., has signed a contract with UroGPO, the largest Group Purchasing Organization for urology private practice clinics in the U.S. The three-year agreement is for Ambu’s aScope 4 Cysto and aView 2 Advance HD Monitor. The aScope 4 Cysto is the only single-use cystoscope on contract with UroGPO. The partnership with UroGPO, whose members represents 619 Urology Group Practices and 167 Ambulatory Surgery Centers will accelerate Ambu’s entry into the office-based urology segment. 

Cystoscope Market Key Segments: 

By Type 

• Flexible Cystoscope 
• Rigid Cystoscope 

By Application 

• Urology 
• Gynaecology 
• Others 

By End User 

• Hospitals 
• Ambulatory Surgical Centers 
• Others 

Key Global Cystoscope Industry Players 

• Olympus Corporation 
• Stryker Corporation 
• Karl Storz SE & Co. KG 
• Advanced Endoscopy Devices, Inc. 
• Richard Wolf GmbH 
• Maxer Medizintechnik GmbH 
• NeoScope Inc. 
• PENTAX Medical 
• Coloplast Group 
• Laborie, Inc. 

What Report Provides 

• Full in-depth analysis of the parent Industry 
• Important changes in market and its dynamics 
• Segmentation details of the market 
• Former, on-going, and projected market analysis in terms of volume and value 
• Assessment of niche industry developments 
• Market share analysis 
• Key strategies of major players 
• Emerging segments and regional growth potential